Authors
Loading...
Randomized trial uncovers the role of 5-HT2B receptor in regulating cell-cycle progression, indicating potential therapeutic targets.
Nebigil et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: